1-methyl-4-phenylpyridinium has been researched along with Hypertrophy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allegrini, PR; Arendt, T; Bartsch, D; Berns, H; Goemans, C; Hengerer, B; Heumann, R; Kamdem, RH; Lingenhöhl, K; Narz, F; Obst-Pernberg, K; Schellander, K; Wagner, EF; Wahle, P; Waldmeier, PC | 1 |
1 other study(ies) available for 1-methyl-4-phenylpyridinium and Hypertrophy
| Article | Year |
|---|---|
Transgenic activation of Ras in neurons promotes hypertrophy and protects from lesion-induced degeneration.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Axotomy; Brain; Cell Count; Cell Size; Cells, Cultured; Choline O-Acetyltransferase; Enzyme Activation; Hypertrophy; Mice; Mice, Transgenic; Mitogen-Activated Protein Kinases; Motor Neurons; Mutation; Neurodegenerative Diseases; Neuropeptide Y; Neuroprotective Agents; Oxidopamine; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins p21(ras); RNA, Messenger; Signal Transduction; Substantia Nigra; Tyrosine 3-Monooxygenase | 2000 |